Insurers must rule within 30 days on prior approval for sole rare disease drugs
Health plans and insurers must finish prior authorization within 30 days of the first request for an FDA-approved rare disease drug that a specialist prescribes as medically necessary, when it is the only FDA-approved treatment for that disease. It applies to new and renewed plans.
Who it affects
Health plans, insurers and patients with rare diseases
When
This law takes effect on January 1, 2027. California laws take effect on January 1 of the year after they are signed, unless the law says otherwise.
- : Signed into law
- : This law takes effect
Official text
California AB 1887: Prescription drug coverage for rare diseases.
On California Legislative Information. The official text is what counts; read it before you act.
Not legal advice. Plain-English summaries to help you find what changes and when. Not legal advice: read the official text, and ask a lawyer about your situation.